Epigral Share Price

NSE
EPIGRAL •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Epigral Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
New 52W High in past week
49.6
TTM PE Ratio
Below industry Median
37.3
Price to Book Ratio
Below industry Median
7.4
Dividend yield 1yr %
Below industry Median
0.2
TTM PEG Ratio
PEG TTM is negative
-3.9

Epigral Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Revenue
QuarterlyYearly
Jun 2024 - 651.2 Cr Mar 2024 - 1935.7566 Cr
Mar 2024 - 524.633 Cr Mar 2023 - 2196.3836 Cr
Dec 2023 - 471.5201 Cr Mar 2022 - 1555.0522 Cr
Sep 2023 - 478.1461 Cr Mar 2021 - 830.7893 Cr
Jun 2023 - 454.8924 Cr - Cr
Net Profit/Loss
QuarterlyYearly
Jun 2024 - 86.01 Cr Mar 2024 - 195.8377 Cr
Mar 2024 - 76.6689 Cr Mar 2023 - 353.3075 Cr
Dec 2023 - 49.309 Cr Mar 2022 - 252.7868 Cr
Sep 2023 - 38.1826 Cr Mar 2021 - 100.839 Cr
Jun 2023 - 31.6772 Cr - Cr

Epigral Ltd shareholding Pattern

Promoter
71.6%
Foreign Institutions
1.5%
Domestic Institutions
0.2%
Public
26.8%
Promoter
71.5%
Foreign Institutions
1.4%
Public
27.1%
Promoter
71.4%
Foreign Institutions
1.2%
Domestic Institutions
0.1%
Public
27.4%
Promoter
71.4%
Foreign Institutions
1.1%
Domestic Institutions
0.1%
Public
27.4%
Promoter
71.4%
Foreign Institutions
1.2%
Domestic Institutions
0.1%
Public
27.4%
Promoter
71.3%
Foreign Institutions
1.2%
Public
27.4%

Epigral Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
2,176.00
10Day EMA
2,180.20
12Day EMA
2,174.10
20Day EMA
2,136.10
26Day EMA
2,103.50
50Day EMA
1,975.20
100Day EMA
1,766.90
200Day EMA
1,528.10
5Day SMA
2,177.10
10Day SMA
2,226.90
20Day SMA
2,144.90
30Day SMA
2,064.00
50Day SMA
1,982.80
100Day SMA
1,685.00
150Day SMA
1,531.80
200Day SMA
1,408.30
Delivery & Volume
Day
Combined Delivery Volume- 20519 Rs
NSE+BSE Traded Volume- 44437 Rs

Week
Combined Delivery Volume- 43907 Rs
NSE+BSE Traded Volume- 130407 Rs

Month
Combined Delivery Volume- 64678 Rs
NSE+BSE Traded Volume- 234468 Rs

Resistance & Support
2,182.07
Pivot
Resistance
First Resistance
2,205.83
Second Resistance
2,235.87
Third Resistance
2,259.63
Support
First Support
2,152.03
Second support
2,128.27
Third Support
2,098.23
Relative Strength Index
54.74
Money Flow Index
83.15
MACD
70.58
MACD Signal
86.34
Average True Range
122.97
Average Directional Index
38.42
Rate of Change (21)
17.63
Rate of Change (125)
59.48

Epigral Ltd Company background

Founded in: 2007
Managing director: Maulik Jayantibhai Patel
Epigral Limited was erstwhile incorporated as Meghmani Finechem Limited in 2007, which engaged in manufacturing and selling of Chlor Alkali its Derivatives and also in Trading of Agrochemical products. The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021. The ChlorAlkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 202021. The Company is now among the leading players in Indias chlor alkali industry. In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/ each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive Power Plant). The timely commissioning of the plants represented the faith of the management in the longterm potential of the sector and country. The Caustic Soda capacity was expanded by 1,27,000 TPA to 2,94,000 TPA and commissioned in June 2020. The Captive Power Plant capacity was increased by 36 MW to 96 MW, commissioned in June 2020. The Company commissioned a 60,000 TPA Hydrogen Peroxide plant in July 2020. The Company further commissioned the capacity expansion of Caustic Soda manufacturing facility to 400 KTPA by adding 106 KTPA facility, along with expansion of 36 MW Captive Power Plant on 30th September, 2022. It commissioned Epichlorohydrin (ECH) manufacturing facility with a capacity of 50,000 TPA on 1st June, 2022, which is used in varied applications, such as Epoxy Resin, Water Treatment Chemicals, Textiles, Pharmaceuticals, Paper Reinforcement, Synthetic Glycerine, etc. It commissioned CPVC Resinmanufacturing facility with a capacity of 30,000 TPA capacity on 18th July, 2022.In April 2024, the Company commissioned an additional 45,000 TPA capacity of CPVC Resin Plant at its Dahej facility in Gujarat. As a result of this expansion, Companys total CPVC resin capacity reached 75,000 TPA. The Chlorinated Polyvinyl Chloride (CPVC) compound announced the expansion with a capacity of 35,000 TPA with an additional Capex of Rs. 25 Crore in 2024.
Read More

Epigral Ltd FAQs

Epigral Ltd shares are currently priced at 2245.9 on NSE and 2241.05 on BSE as of 10/9/2024 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

The past 1-year return of Epigral Ltd [EPIGRAL] share was 130.69. The Epigral Ltd [EPIGRAL] share hit a 1-year low of Rs. 872.1 and a 1-year high of Rs. 2406.75.

The market cap of Epigral Ltd is Rs. 9040.48 Cr. as of 10/9/2024 12:00:00 AM.

The PE ratios of Epigral Ltd is 36.09 as of 10/9/2024 12:00:00 AM.

The PB ratios of Epigral Ltd is 7.19 as of 10/9/2024 12:00:00 AM

The Mutual Fund Shareholding was 0.05% at the end of 10/9/2024 12:00:00 AM.

You can easily buy Epigral Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -